Veracyte Raises $28 Million
Veracyte Inc., a South San Francisco-based developer of molecular cytology diagnostics, has raised $28 million in Series B funding. Domain Associates led the round, and was joined by return backers Kleiner Perkins Caufield & Byers, TPG Biotech and Versant Ventures. Veracyte previously raised around $22 million.
10 June 2010•2 mins read
